Abstract
Objective To evaluate the effect of oral vitamin D supplementation on colorectal cancer incidence and mortality.
Methods All randomized controlled trials regarding effect of oral vitamin D on colorectal cancer from PubMed, Web of science, Embase and Cochrane Library were searched. Meta analysis and trial sequential analysis of included studies were carried out.
Results Seven RCTs enrolling 72810 participants were included. Compared with placebo, oral vitamin D supplementation was not associated with the incidence of colorectal cancer(RR=1.1,95%CI:0.93-1.31;p=0.28).Subgroup analysis showed no difference in female participants for incidence of colorectal cancer(RR=1.04,95% CI:0.84-1.28;p=0.73). The pooled RR, included 41643 participants, showed no difference in mortality of colorectal cancer(RR= 0.82, 95% CI:0.56 to 1.21; p = 0.32). Trial sequential analysis showed the z-line did not cross the conventional test boundary, TSA monitoring boundary and futility boundaries.
Conclusion Oral vitamin D supplementation offers no benefit on the incidence and mortality of colorectal cancer. However, the RCTs with longer follow-up are needed to ascertain the efficacy of Vitamin D, especially among adults with lower serum 25(OH)D levels in future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest:none
Funding source:none
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.